Cas no 10061-38-8 (Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI))
![Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI) structure](https://ossimg.kuujia.com/scimg/10500/10061-38-8x500.png)
Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI) Chemical and Physical Properties
Names and Identifiers
-
- Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)
- (-)-Epipinoresinol
- 1H,3H-Furo[3,4-c]furan, phenol deriv.
- Phenol,4,4'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2-methoxy-, [1R-(1a,3aa,4b,6aa)]-
- Phenol,4,4'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2-methoxy-, stereoisomer(8CI)
- Symplocosigenol (7CI)
- Symplocosigenol
- 10061-38-8
- F92725
- FS-7739
- 4,4'-((1R,3AS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis(2-methoxyphenol)
- 4-[(3R,3aS,6S,6aS)-6-(4-hydroxy-3-methoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenol
- AKOS040760383
- 4-[(1R,3aS,4S,6aS)-4-(4-hydroxy-3-methoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol
-
- Inchi： 1S/C20H22O6/c1-23-17-7-11(3-5-15(17)21)19-13-9-26-20(14(13)10-25-19)12-4-6-16(22)18(8-12)24-2/h3-8,13-14,19-22H,9-10H2,1-2H3/t13-,14-,19-,20+/m1/s1
- InChI Key： HGXBRUKMWQGOIE-FQZPYLGXSA-N
- SMILES： O1C[C@H]2[C@@H](C3C=CC(=C(C=3)OC)O)OC[C@H]2[C@@H]1C1C=CC(=C(C=1)OC)O
Computed Properties
- Exact Mass: 358.14166
- Monoisotopic Mass: 358.14163842g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 6
- Heavy Atom Count: 26
- Rotatable Bond Count: 4
- Complexity: 431
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 4
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.3
- Topological Polar Surface Area: 77.4?2
Experimental Properties
- Color/Form: Powder
- Density: 1.287±0.06 g/cm3 (20 oC 760 Torr),
- Melting Point: 141.0-141.5 oC (methanol )
- Boiling Point: 556.5±50.0 °C at 760 mmHg
- Flash Point: 290.4±30.1 °C
- Solubility: Very slightly soluble (0.14 g/l) (25 o C),
- PSA: 77.38
- Vapor Pressure: 0.0±1.6 mmHg at 25°C
Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI) Security Information
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Safety Instruction： H303+H313+H333
- Storage Condition：Store at 4 ℃, better at -4 ℃
Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | E18030-5mg |
(–)-epipinoresinol |
10061-38-8 | ,HPLC≥95% | 5mg |
￥4640.0 | 2023-09-08 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN1613-1 mg |
(-)-Epipinoresinol |
10061-38-8 | 1mg |
￥2353.00 | 2022-04-26 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN1613-5mg |
(-)-Epipinoresinol |
10061-38-8 | 5mg |
￥ 3710 | 2023-09-08 | ||
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN1613-1 mL * 10 mM (in DMSO) |
(-)-Epipinoresinol |
10061-38-8 | 1 mL * 10 mM (in DMSO) |
￥ 3810 | 2023-09-08 | ||
| TargetMol Chemicals | TN1613-5mg |
(-)-Epipinoresinol |
10061-38-8 | 5mg |
￥ 3710 | 2024-07-20 | ||
| TargetMol Chemicals | TN1613-5 mg |
(-)-Epipinoresinol |
10061-38-8 | 98% | 5mg |
￥ 3,710 | 2023-07-11 | |
| TargetMol Chemicals | TN1613-1 mL * 10 mM (in DMSO) |
(-)-Epipinoresinol |
10061-38-8 | 98% | 1 mL * 10 mM (in DMSO) |
￥ 3810 | 2023-09-15 | |
| TargetMol Chemicals | TN1613-1 ml * 10 mm |
(-)-Epipinoresinol |
10061-38-8 | 1 ml * 10 mm |
￥ 3810 | 2024-07-20 | ||
| A2B Chem LLC | AE29430-5mg |
(-)-Epipinoresinol |
10061-38-8 | 97.5% | 5mg |
$660.00 | 2024-04-20 | |
| Key Organics Ltd | FS-7739-5mg |
(-)-Epipinoresinol |
10061-38-8 | >95% | 5mg |
￡558.42 | 2025-02-09 |
Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI) Related Literature
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
Additional information on Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)
Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)] and Its Significance in Modern Chemical Biology
Chemical compounds play a pivotal role in the advancement of pharmaceuticals and biotechnology. Among these, Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)], with the CAS number 10061-38-8, has garnered significant attention due to its unique structural properties and potential applications. This compound belongs to a class of molecules that exhibit promising biological activities, making it a subject of extensive research in the field of medicinal chemistry.
The molecular structure of Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)] is characterized by a complex fused ring system consisting of furan and biphenol moieties. This intricate arrangement contributes to its distinct chemical and biological properties. The presence of multiple stereocenters, as indicated by the (1R,3aS,4S,6aS) configuration, further enhances its potential as a chiral building block in drug design.
In recent years, there has been a growing interest in the development of novel therapeutic agents that target specific biological pathways. Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)] has emerged as a compound of interest due to its ability to interact with various biological targets. Studies have shown that this molecule exhibits inhibitory activity against certain enzymes and receptors involved in inflammatory and metabolic disorders. Its potential as an anti-inflammatory agent has been particularly highlighted in preclinical studies.
The synthesis of Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)] presents unique challenges due to its complex stereochemistry. However，recent advancements in synthetic methodologies have made it more feasible to produce this compound in high yields and purity. These advancements include the use of enantioselective catalysis and chiral auxiliaries to facilitate the construction of the stereocenters with high precision.
One of the most exciting aspects of Phenol,4,4'-[(1R，3aS，4S，6aS)-tetrahydro-1H，3H-furo[3， 44-c]furan- 14-diyl]bis[2-methoxy-(9CI)] is its potential application in the development of next-generation drugs. Researchers are exploring its efficacy in treating conditions such as cancer、neurodegenerative diseases、and autoimmune disorders. The compound's ability to modulate key signaling pathways makes it a promising candidate for therapeutic intervention.
The pharmacological profile of this compound is still under investigation，but initial findings suggest that it may have fewer side effects compared to existing treatments. This is particularly important in the context of personalized medicine，where individual patient responses to therapy need to be considered. The unique structural features of Phenol， 44' - [( 11 R。 33 a S。 44 S。 66 a S) - tetrahydro - 11 H、33 H - furo [34 - c ] furan - 11、44 - diyl ] bis [22 - methoxy - (99CI)] make it an attractive scaffold for further drug development.
In conclusion，Phenol、44' - [(11 R、33 a S、44 S、66 a S) - tetrahydro - 11 H、33 H - furo [34 - c ] furan - 11、44 - diyl ] bis [22 - methoxy -(99CI)](CAS no:10061-38-8) is a compound with significant potential in the field of chemical biology and pharmaceuticals。 Its complex structure、unique stereochemistry、and promising biological activities make it a valuable asset for researchers working on innovative drug therapies。 As our understanding of its properties continues to grow，we can expect to see more applications emerging from this fascinating molecule.
10061-38-8 (Phenol,4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2-methoxy-(9CI)) Related Products
- 133-04-0((-)-Asarinin)
- 27003-73-2(Lariciresinol)
- 24404-50-0(Epipinoresinol)
- 1177-14-6(DL-Syringaresinol)
- 13060-14-5(Yangambin)
- 105256-12-0(3-Furanmethanol,tetrahydro-2-(4-hydroxy-3,5-dimethoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-,(2R,3S,4S)-rel-)
- 487-39-8(Phillygenin)
- 133-05-1((-)-Asarinin)
- 31008-18-1(Magnolin)
- 607-80-7(Sesamin)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier